Where does Iridium Medical Technology Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Iridium Medical Technology Co., Ltd. ranks #35,970 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Iridium Medical Technology Co., Ltd. hold?

Iridium Medical Technology Co., Ltd. holds 7 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Iridium Medical Technology Co., Ltd.'s Innovation Score?

Iridium Medical Technology Co., Ltd. has an Innovation Score of 29.9 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Iridium Medical Technology Co., Ltd.'s patent grant rate increasing or decreasing?

Iridium Medical Technology Co., Ltd.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Iridium Medical Technology Co., Ltd.'s patents?

Iridium Medical Technology Co., Ltd.'s patents average 12.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Iridium Medical Technology Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Iridium Medical Technology Co., Ltd.

Q: What technology areas does Iridium Medical Technology Co., Ltd. focus on?

Iridium Medical Technology Co., Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 6 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Iridium ranks #35,970 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 6 technology areas.

#35,970
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.9/100): 12.3
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35970 · Foreign Corporation #35,970 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,970/49,997
PHOTO-FINISH Ipco Germany
CPC-NARROW A61N · 6 areas
INNOV-THIN 29.9/100
CLAIMS-RICH 12.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ipco Germany GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Iridium Medical… · this assignee

30
3D Lighting… · lowest

7

What this shows Iridium's Innovation Score is 29.9/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Iridium's grants concentrate

Iridium Medical Technology Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 85.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2017. By volume, Iridium sits between Ipco Germany GMBH and Ishigaki Company Limited.

Iridium's three-year grant acceleration

Iridium Medical Technology Co., Ltd. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ipco Germany

7
IQX

7
Iray Technology

7
Ircad

7
Ironclad

7
IRP Nexus Group

7
Isct

7
Ishigaki

7
Iridium Medical T… ◀

7

What this shows Iridium holds 7 patents at rank #35,871, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Iridium

By rank, the assignees closest to #35,871 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Iridium's primary technology class.

Iridium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Iridium Medical Technology Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	42.9%
2017	1	14.3%
2020	1	14.3%
2022	1	14.3%
2025partial year	1	14.3%

Which technologies does Iridium Medical Technology Co., Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

H01L - Semiconductor Devices NOT Covered BY Class H10 4

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 3

Y10T - Technical Subjects Covered BY Former US Classification 2

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#35,970

of 49,997 tracked assignees

Innovation Score

29.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Iridium Medical Technology Co., Ltd.'s patent record in context - here's where to go next.

Iridium Medical Technology Co., Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 85.7% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #35,970 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Iridium Medical Technology Co., Ltd. against Ipco Germany GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.